Valuation: Balchem Corporation

Market Cap 544.41Cr 485.94Cr 448.31Cr 407.3Cr 764.09Cr 52TCr 775.84Cr 5.4TCr 2.13TCr 27TCr 2.04TCr 2TCr 86TCr P/E 2026 *
32.1x
P/E 2027 * 30.8x
Enterprise Value 547.96Cr 489.11Cr 451.23Cr 409.96Cr 769.08Cr 52TCr 780.9Cr 5.44TCr 2.14TCr 27TCr 2.06TCr 2.01TCr 86TCr EV / Sales 2026 *
4.84x
EV / Sales 2027 * 4.52x
Free-Float
99.51%
Yield 2026 *
0.68%
Yield 2027 * 0.75%
1 day+1.43%
1 week+1.58%
Current month+5.01%
1 month+2.87%
3 months+6.87%
6 months-1.11%
Current year+12.96%
1 week 169.72
Extreme 169.7152
173.43
1 month 161.05
Extreme 161.0501
174.29
Current year 152.58
Extreme 152.58
183.9
1 year 147.18
Extreme 147.18
183.9
3 years 110.74
Extreme 110.74
186.03
5 years 110.15
Extreme 110.1456
186.03
10 years 67.71
Extreme 67.71
186.03
Manager TitleAgeSince
Chief Executive Officer 61 28/04/2015
Director of Finance/CFO 49 04/02/2019
Chief Tech/Sci/R&D Officer 56 01/10/2025
Director TitleAgeSince
Director/Board Member 63 16/09/2010
Chairman 61 01/01/2017
Director/Board Member 59 15/09/2015
Date Insider Type Main position Quantity % Market Cap. Importance
01/04/26 Other

Controller/Auditor

8,646 0.0270%
11/02/26 Free

Director

870 0.0027%
11/02/26 Free

Director

870 0.0027%
Change 5-day change 1-year change 3-year change Capi.($)
+1.43%+1.58%+10.32%+41.45% 544.41Cr
+1.46%+0.51%+5.91%+82.77% 8.19TCr
-0.38%+1.17%+11.77%+39.37% 4.46TCr
-1.80%-0.68%+2.46%-16.03% 3.59TCr
-0.43%-0.66%+8.88%+17.27% 3.38TCr
-0.62%+4.57%+16.57%+70.40% 3.34TCr
-0.38%-1.22%-4.29%+21.40% 2.59TCr
-1.10%-1.36%+52.27%+45.05% 2.51TCr
+0.71%+2.66%-43.50%-38.32% 1.82TCr
-3.54%-6.78%+32.98%+9.05% 1.61TCr
Average -0.44%+1.80%+9.34%+27.24% 3.2TCr
Weighted average by Cap. -0.19%+1.77%+9.19%+38.24%

Financials

2026 *2027 *
Net sales 113.16Cr 101.01Cr 93Cr 85Cr 158.83Cr 11TCr 161.27Cr 1.12TCr 442.22Cr 5.62TCr 424.77Cr 415.67Cr 18TCr 119.58Cr 106.74Cr 98Cr 89Cr 167.83Cr 11TCr 170.41Cr 1.19TCr 467.29Cr 5.93TCr 448.85Cr 439.23Cr 19TCr
Net income 17Cr 16Cr 14Cr 13Cr 25Cr 1.66TCr 25Cr 173.46Cr 68Cr 867.73Cr 66Cr 64Cr 2.75TCr 18Cr 16Cr 15Cr 14Cr 26Cr 1.73TCr 26Cr 180.78Cr 71Cr 904.36Cr 68Cr 67Cr 2.86TCr
Net Debt 3.55Cr 3.17Cr 2.92Cr 2.66Cr 4.98Cr 336.38Cr 5.06Cr 35Cr 14Cr 176.24Cr 13Cr 13Cr 558.31Cr -3.97Cr -3.54Cr -3.27Cr -2.97Cr -5.57Cr -375.85Cr -5.65Cr -39Cr -16Cr -196.91Cr -15Cr -15Cr -623.81Cr
Projected Income Statement - Annual - Balchem Corporation
Logo Balchem Corporation
Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
Employees
1,379
Date Price Change Volume
22/26/22 $173.23 +1.43% 4,93,935
21/26/21 $170.78 -0.49% 4,52,862
20/26/20 $171.62 +0.70% 3,36,335
19/26/19 $170.42 -0.18% 3,63,498
16/26/16 $170.73 +0.12% 1,97,304
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
A
MarketScreener Ratings - Balchem Corporation
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
173.23USD
Average target price
209.25USD
Spread / Average Target
+20.79%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Balchem Corporation
  1. Stock Market
  2. Stocks
  3. BCPC Stock